文献速递产科

早期妊娠期糖尿病后的产后糖耐量异常

Postpartum glucose intolerance following early gestational diabetes mellitus.
PubMed 文献 · Am J Obstet Gynecol MFM · 2022-03-07

本研究为一项随机对照试验的二次分析,纳入肥胖且单胎妊娠患者,比较14至20周早期筛查与24至28周常规筛查诊断的妊娠期糖尿病与产后糖代谢异常的关系。结果显示早期妊娠期糖尿病组产后糖代谢异常比例高于常规筛查组(36.7% vs 14.6%;比值比3.38;95%置信区间1.31-8.73)。

要点

  • 在肥胖孕妇中,20周前诊断的妊娠期糖尿病与产后糖代谢异常风险升高相关(比值比3.38;95%置信区间1.31-8.73)。
  • 早期妊娠期糖尿病组产后糖代谢异常36.7%,常规筛查组14.6%。
  • 产后口服葡萄糖耐量试验完成率低但两组相似。

核心结论

  • 尽管产后口服葡萄糖耐量试验完成率低,在肥胖患者队列中,20周前诊断的妊娠期糖尿病似乎比常规筛查诊断的妊娠期糖尿病有更高的产后糖代谢异常风险。
  • 需要更大规模的研究来证实这些发现,但产后随访和糖尿病检测对于改善早期妊娠期糖尿病患者的长期健康可能更为重要。

研究设计与样本

  • 本研究为一项随机对照试验的二次分析,该试验比较了妊娠14至20周早期筛查与24至28周常规筛查妊娠期糖尿病。
  • 纳入标准为肥胖、单胎、非畸形妊娠,且在原研究主要中心诊断妊娠期糖尿病的患者。
  • 共纳入119例患者,其中30例在<20周筛查诊断,89例在24至28周筛查诊断。

主要发现

  • 早期妊娠期糖尿病组发生产后糖代谢异常的患者多数为临床诊断(7/11),而常规筛查组无临床诊断的产后糖代谢异常患者。
  • 完成产后葡萄糖耐量试验的早期妊娠期糖尿病患者全部(100%)存在糖代谢异常,而常规筛查诊断的妊娠期糖尿病患者仅45%存在糖代谢异常。
  • 两组产后随访就诊比例及随访时间相似。
  • 产后葡萄糖耐量试验完成率低,但两组相似。

关键数值与推荐

  • 产后糖代谢异常定义为产后6周2小时口服葡萄糖耐量试验任何异常,或延迟葡萄糖耐量试验时基于高血糖需药物治疗的临床诊断。
  • 早期妊娠期糖尿病组产后糖代谢异常36.7% vs 常规筛查组14.6%,比值比3.38(95%置信区间1.31-8.73)。
  • 完成产后葡萄糖耐量试验者中,早期妊娠期糖尿病组糖代谢异常100% vs 常规筛查组45%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 需要更大规模的研究来证实这些发现。
  • 产后葡萄糖耐量试验完成率低。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Patients with gestational diabetes mellitus are at increased risk for type 2 diabetes mellitus or glucose intolerance postpartum compared with those without diabetes mellitus. OBJECTIVE: We aimed to evaluate the association between early gestational diabetes mellitus and postpartum dysglycemia compared with gestational diabetes mellitus diagnosed by routine screening in a cohort of patients with obesity. STUDY DESIGN: This was a secondary analysis of a randomized controlled trial of patients with obesity and singleton, nonanomalous gestations that compared early gestational diabetes mellitus screening at 14 to 20 weeks of gestation with routine screening at 24 to 28 weeks of gestation. Patients were included in this analysis if they were diagnosed with gestational diabetes mellitus at the primary study site. The primary outcome was postpartum dysglycemia, defined as any abnormality on 2-hour oral glucose tolerance test 6 weeks postpartum or clinical diagnosis based on hyperglycemia requiring pharmacotherapy after delivery with deferred glucose tolerance test. Maternal characteristics and outcomes were compared in bivariable analysis, and logistic regression estimated the association between early gestational diabetes mellitus and postpartum dysglycemia. RESULTS: Of 119 patients included in this analysis, 30 were diagnosed by screening at <20 weeks of gestation and 89 at 24 to 28 weeks of gestation. Patients were overall similar in baseline characteristics. Patients with early gestational diabetes mellitus were more likely to have postpartum dysglycemia than those with gestational diabetes mellitus diagnosed with routine screening (36.7% vs 14.6%; odds ratio, 3.38; 95% confidence interval, 1.31-8.73). Most patients with early gestational diabetes mellitus who had postpartum dysglycemia were diagnosed clinically (n=7/11), whereas none of the patients with gestational diabetes mellitus established by routine testing were diagnosed with postpartum dysglycemia clinically. All (100%) patients with early gestational diabetes mellitus who completed a postpartum glucose tolerance test had dysglycemia compared with only 45% of patients with gestational diabetes mellitus diagnosed on routine screening. The proportion of patients who followed up for postpartum visits and the timing of follow-up were similar between groups. Postpartum glucose tolerance test completion was low but also similar between groups. CONCLUSION: Although postpartum glucose tolerance test completion is low, patients with gestational diabetes mellitus before 20 weeks of gestation, seem to be at higher risk for postpartum dysglycemia than those with gestational diabetes mellitus diagnosed at routine screening in a cohort of patients with obesity. Larger studies are needed to confirm these findings, but postpartum follow-up and diabetes mellitus testing may be even more important to improve long-term health in patients with early gestational diabetes mellitus.

来源:Am J Obstet Gynecol MFM,查看原文。版权归原作者所有。

引用

  1. Champion ML, Battarbee AN, Biggio JR, et al. Postpartum glucose intolerance following early gestational diabetes mellitus. Am J Obstet Gynecol MFM. 2022. PMID: 35272093. doi:10.1016/j.ajogmf.2022.100609

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。